AKR vs MRNA · P/E 70, rev $410.8M vs rev $145.0M
Acadia Realty Trust (AKR) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Acadia Realty Trust (AKR) is a reit - retail company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported AKR revenue for 2025-12-31 was $410.8M. Net income was $16.9M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. AKR currently screens at market cap $3.16B and trailing P/E 70.3.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AKR currently screens at market cap $3.16B and trailing P/E 70.3. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AKR and MRNA stock pages for the full models.
Not investment advice.